Zn(ii) and Cu(ii) Schiff base complexes having DNA and HSA binding efficacy have been exploited as cancer therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Das et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: